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␤-Cell replacement therapy via islet transplantation is a promising treatment for type 1 diabetes; however, such an approach is limited by the shortage of donor organs. Significant efforts are currently being directed at the generation of large numbers of insulinproducing cells in vitro from embryonic or adult stem cells, adult pancreatic islets, liver cells or other sources including mesenchymal stem/stromal cells (MSCs)
. So far, these approaches have met with limited success in vivo.
We [5] and others [6] [7] [8] [9] . Recently, we provided evidence that hIPCs may be a specialized type of MSC that can differentiate to insulin-expressing cells in vivo [10] and that have epigenetic markings at the insulin gene similar to those found in adult ␤ cells, which may reflect a commitment towards endocrine differentiation [11] . [12] . [13] [14] [15] [5] . Moreover, we showed recently that mesenchymal hIPCs exhibit nuclear and diffuse cytoplasmic localization of ␤-catenin whereas ␤-catenin in hIPCs in 4-day clusters exhibits cell surface distribution [16] . [5] and differentiate and mature to functional cells that secrete human C-peptide in response to glucose when transplanted under the kidney capsules of NOD-SCID mice [10] . Here Fig. 2A-D) . Moreover, cells within 8 of 12 grafts after 1 to 5 weeks stained positively for vimentin and SMA but not for insulin or glucagon (Fig. 2E-H (Fig. 5) . The reversible reduction in (Fig. 7D) [18, 19] . [20] [21] [22] [23] [24] . A recent study, using an in vitro cell lineage approach, demonstrated that human ␤-cells can be induced to transition to cells with a mesenchymal phenotype and proliferate in vitro [25] . Another report, using adenoviral vectors to specifically label different endocrine cell types in human islets, shows de-differentiation of endocrine cells to a ductal progenitor-like cell [26] . These studies support the idea of human islet plasticity and de-differentiation in vitro.
previously reported that mesenchymal-like cells derived from adult human islets can be expanded and induced to differentiate to insulin-expressing islet-like cells, acquiring epithelial character in vitro. The proliferating human islet-derived precursor cells (hIPCs) that we have isolated display many characteristics of MSCs including adherence to plastic tissue culture dishes, expression of mesenchymal cell-surface antigens and differentiation to various mesodermal tissues such as fat, cartilage and bone
Vimentin is a type of intermediate filament protein normally expressed in cells of mesenchymal origin and generally absent
The rapid up-regulation of vimentin expression has been described in epithelial cells involved in physiological and pathological processes that require cell migration and has been interpreted as a sign of epithelial-to-mesenchymal transition (EMT)
The distribution of ␤-catenin at the cell surface of hIPCs in ECCs is an important component of an epithelial phenotype. hIPC ECCs can differentiate further to insulin-expressing cells in vitro
(SMA). Immunostaining of some recovered ECC grafts after transplantation under the kidney capsule of NOD-SCID mice demonstrated a mixed population of cells expressing either the endocrine markers (C-peptide and glucagon) and other cells expressing mesenchymal markers (vimentin [VIM] and ␣-SMA), or both (upper panel). Some recovered grafts stained positively only for VIM or ␣-SMA (lower panel). Experiments were performed with ECCs from three different donors. G ϭ graft, K ϭ kidney. (A-D ϫ40, E-H ϫ25).
transferred to medium containing 10% FBS, most of the cells migrating out from the ECCs after 72 hrs exhibited nuclear
Fig. 3 FBS induces epithelial-to-mesenchymal transition. (A) FBS causes migration of mesenchymal cells from hIPC epithelial cell clusters (ECCs). hIPC ECCs formed during a 6-day incubation in serum-free medium were transferred to medium containing 10% foetal bovine serum (FBS). The time course of the morphological changes was recorded by photomicroscopy. (B) Changes in mRNA levels of genes associated with mesenchymal, endocrine or epithelial phenotypes. Quantitative real time PCR analysis of mRNA levels of nine selected genes in proliferating hIPCs immediately prior to the start of the experiment (day 0 in medium containing 10% FBS) (ECCs formed after 6 days in SFM) and ECCs transferred to medium containing 10% FBS for 6 days. mRNA values of each transcript were normalized to levels of GAPDH mRNA. Fold changes relative to the mesenchymal state (d0) were calculated based on the comparative Ct method. The bars indicate the upper value range which was calculated using standard propagation of error methods. Experiments were performed in duplicate (two different donors) for each data point. Vimentin (VIM), fibroblast-specific protein-1 (S100A4), snail1 (SNAI1), snail2 (SNAI2), insulin (INS), glucagon (GCG), somatostatin (SST), claudin 3 (CLDN3) and claudin 4 (CLDN4
Discussion
A variety of cell types within the endocrine, exocrine or ductal compartments of murine and human pancreases have been described as potential pancreas-specific precursor cells and different strategies for their isolation and expansion have been used
Our laboratory [10] and others [24, 27, 28] (Fig. 2) . Moreover, related results were seen in mouse grafts of adult human islets, where we observed a significantly higher number of vimentin-positive cells than that found in islets in situ (Fig. 8) .
In [13-15, 31, 32] . For example, it has been suggested that EMT occurs in kidney and lung allografts and plays a role in progressive deterioration of the grafts [17, [33] [34] [35] . Weir and co-workers reported expression of vimentin mRNA as a marker of stromal fibroblasts in islet grafts from normal and diabetic recipients and suggested that these cells may be part of the process of angiogenesis [36] . If this were the case, the stromal cells could have been formed by endothelial-to-mesenchymal transition [37] [38] [39] [41, 42] .
hIPC ECCs formed in vitro, a majority of cells express nonfilamentous vimentin but a few may be mesenchymal cells that express filamentous vimentin. It is possible that in hIPC ECC grafts within mice, some cells of a minor mesenchymal population survive and proliferate, while the major fraction of cells do not proliferate or die. Similarly, in grafts of freshly isolated adult human islets, a minor population of vimentin-expressing cells may have
Fig. 5 Comparison of CD73/90/105 expression in hIPCS, ECCs and ECCs transferred to medium containing 10% FBS for 3, 7 and 11 days. Expression of cell surface markers CD73/90/105 was assessed in proliferating hIPCs, 4-day ECCs and 4-day ECCs transferred to media containing 10% FBS for 3, 7 or 11 days. Expression of CD90 and CD105 decreased in 4-day ECCs in comparison with hIPCs and increased upon return to medium containing 10% FBS. In contrast, expression of CD73 did not change significantly. Fluorophore-labelled antibodies for FACS analysis were directed against human CD73 (PE), CD90 (FITC) and CD105 (APC).
Fig. 6 Different effects of foetal bovine, adult mouse and adult human sera on transition of ECCs to a mesenchymal state and on migration of mesenchymal hIPCs. (A) hIPC 4-day ECCs were incubated in fresh medium
Fig. 7 Mitomycin C-treated hIPCs that do not proliferate undergo mesenchymal-toepithelial-to-mesenchymal transitions. (A) Monolayer cultures of mitomycin C-treated hIPCs incubated with medium containing 10% FBS. (B) Mitomycin C-treated hIPCs were harvested with trypsin and incubated in SFM for 4 days. (C) ECCs (4 days) comprised of mitomycin C-treated hIPCs were incubated in fresh medium containing 10% FBS. The photomicrograph was taken after 3 days. (D) ECCs were formed with mitomycin C-treated or untreated hIPCs by incubation in medium without serum and re-exposed to SCM for 3 days. Cell counts were made daily of untreated (-) and mitomycin-C treated (---) cells. (*P Ͻ 0.05 and **P Ͻ 0.001 versus day 0, n ϭ 3). proliferated whereas hormone-expressing cells did not expand. Indeed, Ko et al. [29] reported expression of vimentin in proliferating human duct cells, which these authors considered a marker of pancreatic precursor cells, whereas epithelial cells in the pancreases of normal adult human, adult rat or neonatal pig did not express vimentin protein. Similarly, Buerger and colleagues [30] suggested that cells exhibiting vimentin protein expression in invasive breast cancer may be proliferating breast progenitor cells with a bilinear (glandular and myoepithelial) differentiation potential. On the other hand, it is possible that hIPCs within ECCs dedifferentiate in vivo to a mesenchymal phenotype and thereby lose their commitment to endocrine differentiation. A number of studies in development and cancer biology have shown that epithelial cells can transition in response to environmental signals to migratory mesenchymal phenotypes
or they could have been formed by EMT. Abraham and colleagues [21] found vimentinpositive cells concentrated along the graft-kidney border after transplantation of human nestin-positive islet-derived stem/ progenitor cells under the kidney capsule of immunocompetent C57BL/6 mice also. To provide support for the hypothesis that vimentin-expressing cells in hIPC grafts are derived by EMT, we developed an in vitro experimental paradigm that attempts to mimic the situation observed in hIPC ECC grafts. The majority of cells within ECCs formed in vitro exhibit decreased mesenchymal characteristics, that is, epithelial morphology, cell surface ␤-catenin [16] and no migration, no filamentous vimentin and decreased expression of DKK1, CD90 and CD105 mRNAs. Within 36 hrs of addition of FBS, hIPCs migrate out of ECCs, exhibit mesenchymal morphology and up-regulate expression of mesenchymal mRNAs for vimentin, S100A4, and transcription factors snail homologues 1 and 2, while transcripts for endocrine hormones and epithelial markers, claudins 3 and 4, decrease. Although the proportion of proliferating cells also increased, the rapid kinetics of the changes in morphology, migration and gene expression strongly suggested that these changes represented FBS-induced EMT rather than selective expansion of a few residual mesenchymal cells. We confirmed that this was the case by showing that mitomycin C-treated hIPCs that could not proliferate underwent the same mesenchymal-toepithelial-to-mesenchymal transitions as untreated hIPCs. Complementary findings were reported by Rukstalis et al. [40] who showed that several endocrine cell lines could reversibly dedifferentiate to mesenchymal-like cells and that this was mediated, at least in part, by the transcription factors snail 1 and 2, and in studies using mouse islets in which it was shown by lineage tracing that ␤ cells could undergo de-differentiation and generate short-term cultures of mesenchymal cells
Our data also show that adult mouse serum was a more effective stimulus than FBS for EMT of ECCs, while adult human serum was much less effective. The observation that mouse and FBS are more effective than human serum as inducers of EMT raises some concerns regarding choice of serum for culture of MSCs as suggested recently [43, 44] 
Statistical analyses
Statistical significance was determined by using Student's t-test.
